Clinical Trials
18 trialsNCT07529808 2026-05-08
ChefHat-001
BigHat Biosciences, Inc.
Phase 1/2 Not yet recruiting
NCT07567469 2026-05-05
A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals
Phase 1/2 Not yet recruiting
NCT07530666 2026-04-15
Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
Dartsbio Pharmaceuticals Ltd.
Phase 1/2 Not yet recruiting
NCT07504263 2026-03-31
Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
Recurv Pharma Inc
Phase 1/2 Not yet recruiting
NCT07498725 2026-03-27
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
Phase 1/2 Not yet recruiting
NCT07354100 2026-03-04
(BLOOM)
University of Chicago
Phase 1/2 Not yet recruiting
NCT07198321 2025-09-30
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2 Not yet recruiting
NCT07180576 2025-09-18
FORCE
University of Kansas Medical Center
Phase 1/2 Not yet recruiting
NCT07064863 2025-07-17
BCG-TIME
Queen's University
Phase 1/2 Not yet recruiting
NCT07032142 2025-06-22
ARCTURUS
D'Or Institute for Research and Education
Phase 1/2 Not yet recruiting
NCT05754840 2025-05-29
CAN-PONC
University of Manitoba
Phase 1/2 Not yet recruiting
NCT05275374 2025-04-10
ENHANCE
Xynomic Pharmaceuticals, Inc.
Phase 1/2 Not yet recruiting
NCT05896371 2025-03-30
PRODIGY-1
CHU de Quebec-Universite Laval
Phase 1/2 Not yet recruiting
NCT06896552 2025-03-26
Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.
Rabin Medical Center
Phase 1/2 Not yet recruiting
NCT06827080 2025-02-14
Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer
Mianyang Central Hospital
Phase 1/2 Not yet recruiting
NCT06783153 2025-01-20
Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients
Mansoura University
Phase 1/2 Not yet recruiting
NCT06456138 2024-06-13
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
Shanghai Chest Hospital
Phase 1/2 Not yet recruiting
NCT05581875 2022-10-17
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
Hellenic Society of Hematology
Phase 1/2 Not yet recruiting